Receive the latest updates from Matrix Medical in real time to understand product information.

On August 26, 2025, the Ministry of Industry and Information Technology and the National Medical Products Administration jointly announced the second batch of shortlisted units for the innovation task of biomedical materials. Matrix Medical's "tree shaped light sensing intelligent material" was successfully shortlisted with a clear technological path and unique innovation in the field of vascular intervention!

The successful nomination of Matrix Medical is not only a testament to the company's years of deep cultivation in the field of vascular intervention, but also an authoritative recognition of Matrix's technological innovation path by the national platform! Matrix Medical will take this nomination as an opportunity to further integrate research and development resources, focus on the localization of key medical materials, break through foreign technological barriers with original technology, and inject "Matrix power" into the high-quality development of China's biomedical materials industry!

 Award Introduction

The unveiling and leadership of the innovation task for biomedical materials "is a national level innovation task jointly initiated by the Ministry of Industry and Information Technology and the National Medical Products Administration (in accordance with the" MIIT Joint Original Letter [2025] No. 41 "), aimed at focusing on the" bottleneck "technologies in the field of biomedical materials, selecting high-quality enterprises to lead research and development, promoting independent and controllable materials, breaking foreign monopolies, and building a solid foundation for the safety of the medical device industry.

Tree like photosensitive intelligent material

In the field of vascular intervention, dendritic photosensitive intelligent materials have shown disruptive potential, with typical applications such as the "Natural Vascular Stent NVS Series" from Matrix Medical.

Currently, Matrix Medical has linked up the upstream and downstream forces of the industry chain, building a full chain technology reserve system of "research and development production application", in order to drive breakthroughs in China's biomedical materials technology, industrial upgrading, and strategic reserves, and help China move from a "follower" of medical polymer materials to an "innovation leader".